After ~6 years of fruitful partnership, we are proud to announce the launch of a booklet with TransQST results:
“Advances in Quantitative Systems Toxicology – The premise of TransQST”.
Check it out on our website👇
https://t.co/URkKIu7dOT
@IHIEurope#drugsafety#drugdiscovery
Our latest paper describing species differences in hepatic stress response pathway capacities is now out @ToxSci. Funded by @transqst@The_MRC. We're now exploring the broader scope, mechanistic basis and implications of these differences - more to come!
https://t.co/yOYmkKgN0o
The BioModels - Model of the Year Competition 2023 is now open! We encourage all modellers to submit their models and enter the competition. Check it out here: https://t.co/9ln8Rsof2Z
📣Calling all early-career researchers who develop systems biology models! Our @biomodels colleagues have launched the first edition of their ‘Model of the year’ competition.
Check out the entry requirements and submit yours for a chance to win! 🏆
https://t.co/1gk4zSJt27
TransQST symposium was hold today as part of the #ICT2022 congress.
Congratulations to all the team for their excellent presentations!
#Toxicology#drugdevelopment
In the new edition of our 'Meet the team' section, we interview our colleagues from UNIVIE. They share with us their vision of the project and of the main challenges and achievements during these past five years: https://t.co/jIHg4LyNh5
Our colleagues from University of Leiden has published a new article in the Plos Computational Biology journal. You can now check this paper here: https://t.co/IrFmvqucmB
You can now read the interview to our colleagues from SYNAPSE taking care of project management and dissemination activities in TransQST. Find the interview here: https://t.co/nscWF9Ha9n
We are happy to share a recent paper from our UKHD colleagues published at the journal Expert Systems with Applications. You may find it here: https://t.co/7W2IYhWtLY
@saezlab@attila_gbr
"At Eli-Lilly, our main focus in TransQST has been on the development of haemodynamic and cardiac models, and we have also been involved in developing new models for liver injury processes", explains Derek Leishman. You can read the entire interview here: https://t.co/cMb9JNRFJ9
Our colleagues from UM work to establish the biological impact of exposures to potentially toxic compounds and to develop safe therapeutic strategies for genetic and non-genetic diseases. We had the opportunity to interview them, find it published here: https://t.co/XXn55pmiuK
A new interview just came out from the oven! This time Sylvain Fouliard, Stéphanie Billiald and Nicolas Sajot from IRIS share with us their experience of working in the TransQST project. You can read it here: https://t.co/LncrO07meD
Another project milestone accomplished! Article showcasing work from the TransQST Heart workpackage has been published in Frontiers in Pharmacology. You can read it here: https://t.co/QU5tjp8tDi
#drugsafety#drugdiscovery
"TransQST has a realistic and undogmatic approach which allowed researchers to adapt to surprising realities revealed by unexpected experimental data" explain IFADO, our colleagues especialised in liver physiology. You can read their entire interview here: https://t.co/w0PkcEom21
TransQST partner UOXF: "TransQST has allowed us to understand the challenges in safety pharmacology and toxicology, and how modelling and simulation methods can contribute to the field". Check out the whole interview here: https://t.co/TiV3vXZ6EF